Towards Healthcare
Nanomedicine Market Size Envisioned at USD 562.93 Billion by 2032

Nanomedicine Market Size Envisioned at USD 562.93 Billion by 2032

Status: Published Category: Therapeutic Area Insight Code: 5127 Format: PDF / PPT / Excel

Introduction

  • Research Objective
  • Scope of the Study
  • Definition and Taxonomy

Research Methodology

  • Research Approach
  • Data Sources
  • Assumptions

Executive Summary

  • Synopsis
  • Analyst Recommendations

Market Overview 

  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Value Chain Analysis
    • Raw Material Sourcing
    • Manufacturing Process
    • Logistics & Transportation
    • Buyer Preferences
  • Trends
    • Market Trends
    • Technological Trends
  • Porter’s Five Forces Analysis
    • Bargaining Power of Suppliers
    • Bargaining Power of Buyers
    • Threat of Substitute
    • Threat of New Entrants
    • Degree of Competition
  • PESTLE Analysis for 5 Leading Countries
    • Regulatory Framework for Leading Countries/Regions
    • Supply Demand Analysis
    • Production & Consumption Statistics
    • Export Import Statistics
    • Price Trend Analysis

Global Nanomedicine Market Assessment

  • Overview
  • Global Nanomedicine Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Therapeutics
    • In-vitro Diagnostics
    • Drug Delivery
    • In-vivo Imaging
    • Implants
  • Global Nanomedicine Market Size Value (US$) and Volume (Billion Tons), by Indication (2021 – 2033)
    • Clinical Oncology
    • Infectious Diseases
    • Clinical Cardiology
    • Orthopedics
    • Others
  • Global Nanomedicine Market Size Value (US$) and Volume (Billion Tons), by Molecule Type (2021 – 2033)
    • Nanoparticles
      • Metal & Metal Oxide Nanoparticles
      • Liposomes
      • Polymers & Polymer Drug Conjugates
      • Hydrogel Nanoparticles
      • Dendrimers
      • Inorganic Nanoparticles
    • Nanoshells
    • Nanotubes
    • Nanodevices
  • Global Nanomedicine Market Size Value (US$) and Volume (Billion Tons), by Geography (2021 – 2033)
    • North America
    • Europe
    • Asia Pacific
    • Middle East and Africa
    • South America

North America Nanomedicine Market Assessment

  • Overview
  • North America Nanomedicine Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Therapeutics
    • In-vitro Diagnostics
    • Drug Delivery
    • In-vivo Imaging
    • Implants
  • North America Nanomedicine Market Size Value (US$) and Volume (Billion Tons), by Indication (2021 – 2033)
    • Clinical Oncology
    • Infectious Diseases
    • Clinical Cardiology
    • Orthopedics
    • Others
  • North America Nanomedicine Market Size Value (US$) and Volume (Billion Tons), by Molecule Type (2021 – 2033)
    • Nanoparticles
      • Metal & Metal Oxide Nanoparticles
      • Liposomes
      • Polymers & Polymer Drug Conjugates
      • Hydrogel Nanoparticles
      • Dendrimers
      • Inorganic Nanoparticles
    • Nanoshells
    • Nanotubes
    • Nanodevices

Europe Nanomedicine Market Assessment

  • Overview
  • Europe Nanomedicine Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Therapeutics
    • In-vitro Diagnostics
    • Drug Delivery
    • In-vivo Imaging
    • Implants
  • Europe Nanomedicine Market Size Value (US$) and Volume (Billion Tons), by Indication (2021 – 2033)
    • Clinical Oncology
    • Infectious Diseases
    • Clinical Cardiology
    • Orthopedics
    • Others
  • Europe Nanomedicine Market Size Value (US$) and Volume (Billion Tons), by Molecule Type (2021 – 2033)
    • Nanoparticles
      • Metal & Metal Oxide Nanoparticles
      • Liposomes
      • Polymers & Polymer Drug Conjugates
      • Hydrogel Nanoparticles
      • Dendrimers
      • Inorganic Nanoparticles
    • Nanoshells
    • Nanotubes
    • Nanodevices

Asia Pacific Nanomedicine Market Assessment

  • Overview
  • Asia Pacific Nanomedicine Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Therapeutics
    • In-vitro Diagnostics
    • Drug Delivery
    • In-vivo Imaging
    • Implants
  • Asia Pacific Nanomedicine Market Size Value (US$) and Volume (Billion Tons), by Indication (2021 – 2033)
    • Clinical Oncology
    • Infectious Diseases
    • Clinical Cardiology
    • Orthopedics
    • Others
  • Asia Pacific Nanomedicine Market Size Value (US$) and Volume (Billion Tons), by Molecule Type (2021 – 2033)
    • Nanoparticles
      • Metal & Metal Oxide Nanoparticles
      • Liposomes
      • Polymers & Polymer Drug Conjugates
      • Hydrogel Nanoparticles
      • Dendrimers
      • Inorganic Nanoparticles
    • Nanoshells
    • Nanotubes
    • Nanodevices

Middle East and Africa Nanomedicine Market Assessment

  • Overview
  • Middle East and Africa Nanomedicine Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Therapeutics
    • In-vitro Diagnostics
    • Drug Delivery
    • In-vivo Imaging
    • Implants
  • Middle East and Africa Nanomedicine Market Size Value (US$) and Volume (Billion Tons), by Indication (2021 – 2033)
    • Clinical Oncology
    • Infectious Diseases
    • Clinical Cardiology
    • Orthopedics
    • Others
  • Middle East and Africa Nanomedicine Market Size Value (US$) and Volume (Billion Tons), by Molecule Type (2021 – 2033)
    • Nanoparticles
      • Metal & Metal Oxide Nanoparticles
      • Liposomes
      • Polymers & Polymer Drug Conjugates
      • Hydrogel Nanoparticles
      • Dendrimers
      • Inorganic Nanoparticles
    • Nanoshells
    • Nanotubes
    • Nanodevices

South America Nanomedicine Market Assessment

  • Overview
  • South America Nanomedicine Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Therapeutics
    • In-vitro Diagnostics
    • Drug Delivery
    • In-vivo Imaging
    • Implants
  • South America Nanomedicine Market Size Value (US$) and Volume (Billion Tons), by Indication (2021 – 2033)
    • Clinical Oncology
    • Infectious Diseases
    • Clinical Cardiology
    • Orthopedics
    • Others
  • South America Nanomedicine Market Size Value (US$) and Volume (Billion Tons), by Molecule Type (2021 – 2033)
    • Nanoparticles
      • Metal & Metal Oxide Nanoparticles
      • Liposomes
      • Polymers & Polymer Drug Conjugates
      • Hydrogel Nanoparticles
      • Dendrimers
      • Inorganic Nanoparticles
    • Nanoshells
    • Nanotubes
    • Nanodevices

Company Profiles

  • Nanospectra Biosciences, Inc.
    • Company Overview
    • Geographic Footprints
    • Financial Performance
    • Product Portfolio
    • SWOT Analysis
    • R&D Efforts
    • Recent Developments & Strategic Collaborations
      • Product Launch/M&A/Technical Collaboration
  • Pfizer Inc.
  • GE Healthcare
  • Mallinckrodt Pharmaceuticals
  • Merck & Co., Inc.
  • Abbott Laboratories
  • Sigma-Tau Pharmaceuticals, Inc.
  • UCB SA

Conclusion & Recommendations

  • Insight Code: 5127
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: March 2024
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Deepa has certified the degree of Master’s in Pharmacy in the Pharmaceutical Quality Assurance department from Dr D.Y. Patil College of Pharmacy. Her research is focused on the healthcare industry. She is the author or co-author of four Review Articles, which include Solid dispersion a strategic method for poorly soluble drugs and solubility improvement techniques for poorly soluble drugs, Herbal Drugs Used In Treatment Of Cataracts, Nano sponges And Their Application in Cancer Prevention and Ayurvedic Remedies of Peptic ulcer. She has also published a Research Article on the Formulation and Evaluation of Mucoadhesive Tablets of Miconazole cocrystal which was published in GIS Science Journal Volume 9 Issue 8. Her passion for secondary research and desire to take on the challenge of solving unresolved issues is making her flourish is the in the research sector.

FAQ's

Nanomedicines use nanotechnology to diagnose, treat, and prevent diseases by manipulating materials at the nanoscale (1-100 nanometers). They encompass drug delivery systems, imaging agents, and diagnostic tools, offering precise targeting, improved effectiveness, and fewer side effects than traditional treatments.

One significant hurdle in the nanomedicine market is navigating complex regulatory frameworks, which require rigorous testing and approval processes due to the novel nature of nanotechnology-based products. Regulatory agencies often need more standardized guidelines for assessing the safety and efficacy of these innovative therapies, leading to delays and uncertainties in market entry.

The prevalence of cancer and neurological disorders drives demand for nanomedicines, as they offer targeted treatment options with reduced side effects. Additionally, advancements in technology, such as nanocarriers and imaging techniques, enhance the development and efficacy of nanomedicines, further propelling market growth.

American Cancer Society, National Institute of Health, Alziemers Association, World Health Organization, ScienceDirect.

Warning: include(report-detail-graphs.php): failed to open stream: No such file or directory in /home/thealthcre/public_html/report-toc.php on line 509

Warning: include(): Failed opening 'report-detail-graphs.php' for inclusion (include_path='.:/opt/cpanel/ea-php74/root/usr/share/pear') in /home/thealthcre/public_html/report-toc.php on line 509